Daily Archives: February 14, 2020

Taconic Biosciences Expands Humanized Mouse Model Production

Local Production of Critical Immuno-oncology Models Now Available in Europe RENSSELAER, N.Y., Feb. 14, 2020 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now being

New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas

New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas Lugano, Switzerland, February 14, 2020 – Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, today announces that scientific abstracts have been accepted for

Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda

GENEVA, Switzerland, Feb. 14, 2020 (GLOBE NEWSWIRE) — Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a milestone and received a payment under its research and collaboration agreement with

AIR Worldwide Estimates Insured Losses for Winter Storm Ciara-Sabine Will Be Between EUR 1.1 Billion and EUR 1.9 Billion

BOSTON, Feb. 14, 2020 (GLOBE NEWSWIRE) — Catastrophe risk modeling firm AIR Worldwide estimates that insured losses due to wind from Winter Storm Ciara-Sabine will range between EUR 1.1 billion and EUR 1.9 billion, the majority of which are expected in

AKWEL SALES ROSE BY +3.7% IN 2019

13 February 2020 AKWEL SALES ROSE BY +3.7% IN 2019 Outperformance of about 9% compared to global automotive production Confirmation of the target to increase operating profitability in 2019 Adjustment of the 2020 sales growth target to +5% Akwel (FR0000053027,